Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M193,849Revenue $M51,584Net Margin (%)42.7Z-Score2.6
Enterprise Value $M197,267EPS $3.2Operating Margin %30.5F-Score5
P/E(ttm))9.7Cash Flow Per Share $3.5Pre-tax Margin (%)30.5Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %3.2Quick Ratio2.1Cash flow > EarningsN
Price/Sales4.05-y EBITDA Growth Rate %8.5Current Ratio2.3Lower Leverage y-yY
Price/Cash Flow7.2y-y EBITDA Growth Rate %14.1ROA % (ttm)12.8Higher Current Ratio y-yN
Dividend Yield %3.3Insider Buy (3m)0ROE % (ttm)28.8Less Shares Outstanding y-yY
Payout Ratio %60.0Shares Outstanding M6,379ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactup Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEGeorge Soros 2013-06-30 Sold Out -0.06%$27.23 - $31.08
($29.12)
$ 30.394%Sold Out0
PFEJean-Marie Eveillard 2013-06-30 Reduce-0.34%$27.23 - $31.08
($29.12)
$ 30.394%Reduce -54.03%3,017,033
PFEVanguard Health Care Fund 2013-06-30 Reduce-0.87%$27.23 - $31.08
($29.12)
$ 30.394%Reduce -24.15%23,968,323
PFEMichael Price 2013-06-30 Reduce-0.91%$27.23 - $31.08
($29.12)
$ 30.394%Reduce -41.38%347,100
PFEYacktman Focused Fund 2013-06-30 Sold Out -2.21%$27.23 - $31.08
($29.12)
$ 30.394%Sold Out0
PFEDonald Yacktman 2013-06-30 Reduce-2.39%$27.23 - $31.08
($29.12)
$ 30.394%Reduce -99.74%41,700
PFEYacktman Fund 2013-06-30 Sold Out -2.65%$27.23 - $31.08
($29.12)
$ 30.394%Sold Out0
PFEJean-Marie Eveillard 2013-03-31 Add0.23%$25.079 - $28.86
($27.3)
$ 30.3911%Add 57.8%6,562,712
PFERay Dalio 2013-03-31 Reduce-0.01%$25.079 - $28.86
($27.3)
$ 30.3911%Reduce -26.27%57,808
PFERay Dalio 2012-12-31 Add0.01%$23.66 - $26.04
($25.01)
$ 30.3922%Add 73.45%78,400
PFEDavid Dreman 2012-12-31 Reduce-0.23%$23.66 - $26.04
($25.01)
$ 30.3922%Reduce -77.06%110,998
PFERonald Muhlenkamp 2012-12-31 Reduce-1.7%$23.66 - $26.04
($25.01)
$ 30.3922%Reduce -89.46%37,624
PFEJoel Greenblatt 2012-09-30 Add0.02%$22.34 - $24.95
($23.74)
$ 30.3928%Add 40.57%44,666
PFERay Dalio 2012-09-30 Reduce-0.02%$22.34 - $24.95
($23.74)
$ 30.3928%Reduce -54.16%45,200
PFEGeorge Soros 2012-09-30 Reduce-0.12%$22.34 - $24.95
($23.74)
$ 30.3928%Reduce -69.36%165,000
PFEDavid Dreman 2012-09-30 Reduce-0.13%$22.34 - $24.95
($23.74)
$ 30.3928%Reduce -34.04%483,957
PFEJohn Hussman 2012-09-30 Sold Out -0.43%$22.34 - $24.95
($23.74)
$ 30.3928%Sold Out0
PFERay Dalio 2012-06-30 Buy 0.03%$21.42 - $23.21
($22.39)
$ 30.3936%New holding, 98600 sh.98,600
PFERichard Perry 2012-06-30 Sold Out -0.03%$21.42 - $23.21
($22.39)
$ 30.3936%Sold Out0
PFEGeorge Soros 2012-06-30 Reduce-0.08%$21.42 - $23.21
($22.39)
$ 30.3936%Reduce -32.27%538,457
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PFE John Hussman 2014-03-3117,00000.04New Buy
PFE Joel Greenblatt 2014-03-311,014,8080.020.49+356.54%
PFE David Dreman 2014-03-3111,85100.03+16.61%
PFE Ray Dalio 2014-03-31112,10800.03+1.54%
PFE Prem Watsa 2014-03-31235,00000.53
PFE Ruane Cunniff 2014-03-3111,02200
PFE Michael Price 2014-03-31347,1000.011.4
PFE Charles Brandes 2014-03-315,743,7110.092.3-0.41%
PFE Mario Gabelli 2014-03-311,165,5740.020.2-1.53%
PFE Dodge & Cox 2014-03-3164,121,0171.012.1-1.79%
PFE James Barrow 2014-03-3159,895,5710.942.8-2.55%
PFE John Keeley 2014-03-3195,89300.05-8.21%
PFE Ronald Muhlenkamp 2014-03-3141,16900.23-8.77%
PFE Jean-Marie Eveillard 2014-03-317,866,4730.120.67-22.77%
PFE Vanguard Health Care Fund 2014-03-317,276,6220.110.66-40.13%
Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
OLSON LAURIE JExecutive Vice President 2014-06-12Sell36,275$29.533.25view
Germano Geno JGroup President 2014-06-02Sell30,000$29.682.73view
YOUNG JOHN DGroup President 2014-03-17Sell9,000$31.38-2.84view
PFIZER INC10% Owner 2014-03-12Buy272,727$11177.18view
CANGIALOSI LORETTA VSr. Vice President, Controller 2014-03-04Sell102,943$32.05-4.87view
Dolsten MikaelPresident R&D 2014-03-04Sell35,789$32.58-6.41view
SUSMAN SALLYExecutive Vice President 2014-03-04Sell67,585$32.59-6.44view
PFIZER INC10% Owner 2014-02-04Buy227,261$8281.13view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell131,810$30.82-1.07view
DAMELIO FRANK AExecutive Vice President 2014-01-13Sell28,190$30.86-1.2view

Press Releases about PFE :

    Quarterly/Annual Reports about PFE:

      News about PFE:

      Articles On GuruFocus.com
      Although This Hedge Fund Changed Stocks in Three of Them Bet More Jul 21 2014 
      Guru Favorites Top GuruFocus Dividend Growers of the Weeks Jul 01 2014 
      Can Pfizer Make Up Its Loss? May 09 2014 
      Auxier Asset Management's Auxier Report - First Quarter 2014 May 06 2014 
      Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
      Wrong Marketing Lesson by Big Pharma May 03 2014 
      Mario Gabelli on Bill Ackman, Valeant, AT&T, DirecTV and Pfizer May 02 2014 
      Pfizer and Lockheed Martin Top Dividend Growers of the Week Apr 28 2014 
      These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 
      Two Things You Must Know About Pfizer Apr 13 2014 

      More From Our Partners
      Johnson & Johnson Announces $5B Share Buyback - Analyst Blog Jul 22 2014 - ZACKS
      FT: 25 More Firms May Seek Tax Breaks Overseas Jul 22 2014 - FOXBUSINESS

      More From Other Websites
      [video] Don't Expect Tax Inversion Fever to Break Anytime Soon Jul 22 2014
      Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
      Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
      Top U.S. lawmaker wants corporate tax loophole 'plugged now' Jul 22 2014
      U.S. Senate panel to debate wave of corporate tax-avoidance deals Jul 21 2014
      [video] Obstacle races attract sponsors Jul 21 2014
      [video] Spartan Race eyes Olympic placement Jul 21 2014
      Tax inversions allow firms to avoid state taxes Jul 21 2014
      3 Stocks Reiterated As A Buy: PFE, ORCL, PEP Jul 21 2014
      Bristol-Myers/Pfizer Commence Phase IV Study on Eliquis Jul 18 2014
      AbbVie Is Biggest to Quit U.S. Address in $55 Billion Shire Deal Jul 18 2014
      Pep Boys, Buenaventura, Pfizer, Mylan and AstraZeneca highlighted as Zacks Bull and Bear of the Day Jul 18 2014
      Is Roche Eyeing Up A Bid For AstraZeneca plc? Jul 18 2014
      Is Roche Eyeing Up A Bid For AstraZeneca plc? Jul 18 2014
      The Hippie Hobby Lobby: Eden Foods Says No to Birth Control Jul 18 2014
      Pfizer Eyes InnoPharma, Acquisition to Boost Injectables Biz Jul 17 2014
      Pfizer Bolsters Injectables by Buying InnoPharma Jul 17 2014
      Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to... Jul 17 2014
      Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to... Jul 17 2014

      Add Notes, Comments or Ask Questions

      User Comments

      SEENSCO
      ReplySEENSCO - 1 month ago
      PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Email Hide